Market closed

Ligand Pharmaceuticals/$LGND

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Ligand Pharmaceuticals

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Ticker

$LGND
Trading on

Industry

Pharmaceuticals

Employees

58

LGND Metrics

BasicAdvanced
$2.3B
Market cap
48.85
P/E ratio
$2.47
EPS
0.90
Beta
-
Dividend rate
$2.3B
0.9
$120.83
$55.02
112K
12.489
10.567
0.745
0.875
27.40%
1.30%
6.00%
48.85
14.19
2.64
4.82
85.809
-0.76%
160.46%
-17.82%
-15.15%

What the Analysts think about LGND

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Ligand Pharmaceuticals stock.

LGND Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

LGND Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $LGND

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Ligand Pharmaceuticals stock?

Ligand Pharmaceuticals (LGND) has a market cap of $2.3B as of November 14, 2024.

What is the P/E ratio for Ligand Pharmaceuticals stock?

The price to earnings (P/E) ratio for Ligand Pharmaceuticals (LGND) stock is 48.85 as of November 14, 2024.

Does Ligand Pharmaceuticals stock pay dividends?

No, Ligand Pharmaceuticals (LGND) stock does not pay dividends to its shareholders as of November 14, 2024.

When is the next Ligand Pharmaceuticals dividend payment date?

Ligand Pharmaceuticals (LGND) stock does not pay dividends to its shareholders.

What is the beta indicator for Ligand Pharmaceuticals?

Ligand Pharmaceuticals (LGND) has a beta rating of 0.9. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.